BFM
ATRC icon

Boothbay Fund Management’s AtriCure ATRC Stock Holding History

Boothbay Fund Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,545
Closed -$231K – 1401
2024
Q4 		$231K Buy
+7,545
New +$243K 0.01% 1163

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Boothbay Fund Management's ATRC Position: Q1 2025 in Review

Boothbay Fund Management sold out of AtriCure (ATRC) in Q1 2025, closing a stake of 7,545 shares — an estimated $231K sold.

Boothbay Fund Management first reported a position in ATRC in Q4 2024 and held it in 1 quarter. The position peaked at $231K in Q4 2024. 221 funds tracked by Wall St. Rank hold ATRC as of Q1 2025.

  • Boothbay Fund Management reported no remaining AtriCure position as of Q1 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 7,545 AtriCure shares in Q1 2025, an estimated $231K.
  • Boothbay Fund Management first reported a position in AtriCure in Q4 2024 and held it in 1 quarter.
  • Boothbay Fund Management's AtriCure position peaked at $231K in Q4 2024.
  • 221 funds tracked by Wall St. Rank held AtriCure as of Q1 2025.

Based on Boothbay Fund Management's 13F filing for Q1 2025, filed 15 May 2025.